COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Investigational device for patients with non-valvular afib

Trial ID:
IRB-21-7812
Matthew J Price, M.D.
This trial is evaluating the safety and effectiveness of the Amulet device compare to NOAC (non-vitamin K antagonist oral anticoagulants) therapy in patients with non-valvular atrial fibrillation (Afib) at increased risk for ischemic stroke and who are recommended for long tern NOAC therapy.

Inclusion Criteria

Patients must:
  • Be at high risk of stroke or systemic embolism, defined as a CHA2DS2-VASc score of = 3
  • Be eligible for long-term NOAC therapy
  • Be 18 years of age or older
  • Meet all other eligibility criteria

Exclusion Criteria

Patients must not:
  • Require long-term OAC therapy for a condition other than afib
  • Have a history of rheumatic or congenital mitral valve heart disease

Additional Info

  • All treatments and physician visits during this study will take place at Scripps Clinic Anderson Medical Pavilion.
  • For more information, search for NCT# 04226547 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org